These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 22613795

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO.
    Chou FS, Griesinger A, Wunderlich M, Lin S, Link KA, Shrestha M, Goyama S, Mizukawa B, Shen S, Marcucci G, Mulloy JC.
    Blood; 2012 Jul 26; 120(4):709-19. PubMed ID: 22337712
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pontin is a critical regulator for AML1-ETO-induced leukemia.
    Breig O, Bras S, Martinez Soria N, Osman D, Heidenreich O, Haenlin M, Waltzer L.
    Leukemia; 2014 Jun 26; 28(6):1271-9. PubMed ID: 24342949
    [Abstract] [Full Text] [Related]

  • 5. The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells.
    Landrette SF, Madera D, He F, Castilla LH.
    Leukemia; 2011 Apr 26; 25(4):655-62. PubMed ID: 21263445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network.
    Zaidi SK, Dowdy CR, van Wijnen AJ, Lian JB, Raza A, Stein JL, Croce CM, Stein GS.
    Cancer Res; 2009 Nov 01; 69(21):8249-55. PubMed ID: 19826043
    [Abstract] [Full Text] [Related]

  • 8. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
    Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T, Takenaka K, Mizuno S, Gondo H, Okamura T, Dohy H, Niho Y.
    Blood; 1996 Jun 01; 87(11):4789-96. PubMed ID: 8639850
    [Abstract] [Full Text] [Related]

  • 9. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
    Ptasinska A, Pickin A, Assi SA, Chin PS, Ames L, Avellino R, Gröschel S, Delwel R, Cockerill PN, Osborne CS, Bonifer C.
    Cell Rep; 2019 Sep 17; 28(12):3022-3031.e7. PubMed ID: 31533028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.
    Matsuura S, Yan M, Lo MC, Ahn EY, Weng S, Dangoor D, Matin M, Higashi T, Feng GS, Zhang DE.
    Blood; 2012 Mar 29; 119(13):3155-63. PubMed ID: 22223820
    [Abstract] [Full Text] [Related]

  • 12. C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice.
    Wang YY, Zhao LJ, Wu CF, Liu P, Shi L, Liang Y, Xiong SM, Mi JQ, Chen Z, Ren R, Chen SJ.
    Proc Natl Acad Sci U S A; 2011 Feb 08; 108(6):2450-5. PubMed ID: 21262832
    [Abstract] [Full Text] [Related]

  • 13. Cooperation between constitutively activated c-Kit signaling and leukemogenic transcription factors in the determination of the leukemic phenotype in murine hematopoietic stem cells.
    Zheng X, Oancea C, Henschler R, Ruthardt M.
    Int J Oncol; 2009 Jun 08; 34(6):1521-31. PubMed ID: 19424569
    [Abstract] [Full Text] [Related]

  • 14. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A, Singh AA, Prange KHM, Tijchon E, Oerlemans M, Dirks R, Ter Huurne M, Wierenga ATJ, Janssen-Megens EM, Berentsen K, Sharifi N, Kim B, Matarese F, Nguyen LN, Hubner NC, Rao NA, van den Akker E, Altucci L, Vellenga E, Stunnenberg HG, Martens JHA.
    Cell Rep; 2016 Nov 15; 17(8):2087-2100. PubMed ID: 27851970
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway.
    Li Y, Gao L, Luo X, Wang L, Gao X, Wang W, Sun J, Dou L, Li J, Xu C, Wang L, Zhou M, Jiang M, Zhou J, Caligiuri MA, Nervi C, Bloomfield CD, Marcucci G, Yu L.
    Blood; 2013 Jan 17; 121(3):499-509. PubMed ID: 23223432
    [Abstract] [Full Text] [Related]

  • 16. YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AML.
    Chen Z, Shao YL, Wang LL, Lin J, Zhang JB, Ding Y, Gao BB, Liu DH, Gao XN.
    Oncogene; 2021 Jun 17; 40(22):3786-3798. PubMed ID: 33958724
    [Abstract] [Full Text] [Related]

  • 17. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice.
    Schessl C, Rawat VP, Cusan M, Deshpande A, Kohl TM, Rosten PM, Spiekermann K, Humphries RK, Schnittger S, Kern W, Hiddemann W, Quintanilla-Martinez L, Bohlander SK, Feuring-Buske M, Buske C.
    J Clin Invest; 2005 Aug 17; 115(8):2159-68. PubMed ID: 16025155
    [Abstract] [Full Text] [Related]

  • 18. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
    Bakshi R, Zaidi SK, Pande S, Hassan MQ, Young DW, Montecino M, Lian JB, van Wijnen AJ, Stein JL, Stein GS.
    J Cell Sci; 2008 Dec 01; 121(Pt 23):3981-90. PubMed ID: 19001502
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.
    Fortier JM, Payton JE, Cahan P, Ley TJ, Walter MJ, Graubert TA.
    Leukemia; 2010 May 01; 24(5):950-7. PubMed ID: 20376082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.